Loading graphs…
AI Summary
StalkMCD remains entrenched in a Stage 4 decline with successive lower highs and lower lows under declining EMAs. A recent extreme-oversold rebound into the 9/20/50 EMA zone was rejected on heavier volume, reaffirming supply dominance. The active support-failure pattern signals continuation risk, and short-term conditions remain unfavorable for bullish entries. Immediate selling into rallies near the declining EMA zone offers the best execution opportunity.